PO.CL12.04 · 临床研究

弥散峰度成像预测HPV相关口咽癌的肿瘤缺氧和复发

Diffusion kurtosis imaging to predict tumor hypoxia and recurrence in HPV-associated oropharyngeal cancer

海报缩略图:弥散峰度成像预测HPV相关口咽癌的肿瘤缺氧和复发
编号 2615 展板 6 时间 4/20 09:00–12:00 区域 Section 47 主讲 David Miller, MD
分会场 Molecular Imaging, Radiomics, and Theranostics
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

David Gibbes Miller1, Ramesh Paudyal2, Bill H. Diplas1, James E. Han1, Vaios Hatzoglou3, Nadeem Riaz1, Amita Shukla-Dave2, Nancy Y. Lee1

1Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY,2Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY,3Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY

摘要 Abstract

中文摘要
引言:近期一项II期试验证明了缺氧引导的放化疗(CRT)降级治疗在人乳头瘤病毒相关口咽癌(HPV+ OPC)中的疗效。用于测量缺氧的18F-氟米索硝唑(18F-FMISO)正电子发射断层扫描(PET)尚未广泛普及,限制了缺氧作为影像生物标志物在研究和临床诊疗中的应用。弥散峰度成像(DKI)量化非高斯水分子弥散,尤其是在弥散加权(DW)数据的较高b值下。DKI捕捉微观结构复杂性,反映细胞膜完整性和细胞密度,可能作为缺氧的替代指标。 方法:DW数据取自一项针对T0-2/N1-N2c HPV+ OPC患者的缺氧引导CRT降级治疗II期试验。患者接受了治疗前18F-FMISO成像,以及从治疗前至CRT第4周的系列MRI扫描。收集了纵向淋巴结体积。从多b值DW数据的建模中提取了DKI衍生特征Dapp和Kapp(均值、标准差和偏度)。使用Wilcoxon秩和检验评估其与治疗前缺氧和淋巴结复发的关联。开发了整合体积和DKI衍生特征的随机森林(RF)模型来预测缺氧和复发,并使用SHAP值评估特征重要性。 结果:158名试验患者中有90名具有纵向DW-MRI检查被纳入。治疗前18F-FMISO PET显示25名患者(27.8%)正常氧合,65名(72.2%)缺氧。缺氧肿瘤的治疗前肿瘤体积显著高于正常氧合肿瘤(均值25.7 对 11.3 cm³,p < 0.001),而治疗前DKI衍生特征无显著差异。8名患者发生淋巴结复发,均在降级治疗队列中。整合治疗前DKI特征和肿瘤体积的RF模型预测治疗前缺氧具有良好的判别力(AUC = 0.77),优于仅使用体积的模型(AUC = 0.65,p<0.001)。SHAP分析确定肿瘤体积、Dapp偏度、Dapp均值和Kapp均值为最有意义的预测因子。复发患者在第2-4周的纵向肿瘤体积显著更高,而纵向DKI特征无显著差异。使用第3周体积和DKI特征的模型表现最佳(AUC = 0.79)。SHAP分析确定体积、从治疗前到第3周的体积变化、Kapp偏度和Dapp均值为最有意义的复发预测因子。 结论:缺氧引起的细胞结构和代谢改变可能与复杂组织中水分子运动受限相关。DKI和体积测量对HPV+ OPC的缺氧和复发风险均显示出良好的预测能力。这些发现支持进一步对DKI用于评估肿瘤缺氧和复发风险进行前瞻性验证。
查看英文原文 English abstract
Introduction: A recent phase II trial demonstrated the efficacy of hypoxia-guided chemoradiation (CRT) de-escalation in human papillomavirus-associated oropharyngeal cancer (HPV+ OPC). 18F-fluoromisonidazole (18F-FMISO) positron emission tomography (PET), used to measure hypoxia, is not widely available, limiting use of hypoxia as an imaging biomarker in research and clinical care. Diffusion kurtosis imaging (DKI) quantifies non-Gaussian water diffusion, especially at higher b-values of diffusion weighted (DW) data. DKI captures microstructural complexity, reflects integrity of cell membranes and cellularity, and may serve as a surrogate for hypoxia. Methods: DW data were obtained from a phase II trial of hypoxia-guided CRT de-escalation in patients with T0-2/N1-N2c HPV+ OPC. Patients received pre-treatment 18F-FMISO imaging and serial MRI scans from pre-treatment through week 4 of CRT. Longitudinal nodal volume was collected. DKI-derived features Dapp and Kapp (mean values, standard deviation, and skewness) from modeling of the multiple b-values DW data were extracted. Associations with pre-treatment hypoxia and nodal recurrence were evaluated using Wilcoxon rank-sum tests. Random forest (RF) models integrating volume and DKI-derived features were developed to predict hypoxia and recurrence, with feature importance assessed using SHAP values. Results: 90 of 158 trial patients with longitudinal DW-MRI exams were included. Pre-treatment 18F-FMISO PET demonstrated normoxia in 25 patients (27.8%) and hypoxia in 65 (72.2%). Pre-treatment tumor volume was significantly higher in hypoxic tumors than normoxic tumors (mean 25.7 vs. 11.3 cm³, p < 0.001), while pre-treatment DKI-derived features did not differ significantly. Eight patients had nodal recurrence, all in the de-escalated cohort. An RF model incorporating pre-treatment DKI features and tumor volume predicted pre-treatment hypoxia with good discrimination (AUC = 0.77), outperforming a model using volume alone (AUC = 0.65, p<0.001). SHAP analysis identified tumor volume, Dapp skewness, Dapp mean, and Kapp mean as the most meaningful predictors. Longitudinal tumor volume in weeks 2-4 was significantly higher in patients who recurred, while longitudinal DKI features did not differ significantly. The model using week 3 volume and DKI features had the best performance (AUC = 0.79). SHAP analysis identified volume, volume change from pretreatment to week 3, Kapp skewness, and mean Dapp as the most meaningful predictors of recurrence. Conclusion: Changes in cell architecture and metabolism caused by hypoxia may be associated with restricted movement of water molecules in complex tissues. DKI and volumetric measurement demonstrated good predictive ability for both hypoxia and recurrence risk in HPV+ OPC. These findings support further prospective validation of DKI for assessing tumor hypoxia and recurrence risk.
利益披露 Disclosure
D. G. Miller, None.. R. Paudyal, None.. B. H. Diplas, None.. J. E. Han, None.. V. Hatzoglou, None.. N. Riaz, None.. A. Shukla-Dave, None. N. Y. Lee, Merck Advisory Board. Merck Serono Advisory Board. Nanobiotix Advisory Board. Galera Advisory Board. LEO Stock Option, Advisory Board. SAB Stock Option, Advisory Board. GSK Advisory Board.

← 返回 AACR 2026 检索